What we do
Equity products
Technology Transfer
European Angels Fund (EAF) - Co-investments with Business Angels
Venture capital
The Social Impact Accelerator (SIA)
Lower mid-market
Mezzanine Facility for Growth
Pan-European Venture Capital Fund(s)-of-Funds programme
EFSI Equity instrument
Single EU Equity Financial Instrument
COSME - Equity Facility for Growth
InnovFin Equity
Private equity secondary market transactions
EIF-NPI Equity Platform
Debt products
AGRI Guarantee Facility
Credit enhancement
Cultural and Creative Sectors Guarantee Facility (CCS GF)
ENSI - Securitisation Initiative
Erasmus+ Master Loan Guarantee Facility
EREM debt products
Single EU Debt Financial Instrument
COSME - Loan Guarantee Facility
InnovFin SME Guarantee Facility
The SME Initiative
The SME Initiative Bulgaria
The SME Initiative Finland
The SME Initiative Italy
The SME Initiative Malta
The SME Initiative Romania
The SME Initiative Spain
AGRI Italy Platform Uncapped Guarantee Instrument
Asset Management Umbrella Fund (AMUF)
Inclusive finance
EaSI Financial Instruments
EaSI Capacity Building Investments Window
EaSI Guarantee Instrument
European Progress Microfinance Facility
Entrepreneurs supported through Progress Microfinance
European Fund for Strategic Investments (EFSI)
How does EIF contribute to EFSI
How to apply for EFSI financing
Regional Development - Country and sector-specific initiatives
AGRI Italy Platform Uncapped Guarantee Instrument
Baltic Innovation Fund (BIF)
Central Europe Fund of Funds (CEFoF)
Competitiveness Fund-of-Funds for SMEs in Romania
Regional Fund-of-Funds Romania
La Financière Région Réunion
Deep and Comprehensive Free Trade Area Initiative East Guarantee Facility (DCFTA)
Dutch Venture Initiative (DVI-II)
Dutch Growth Co-Investment Programme
European Recovery Programme (ERP)
ERP-EIF Co-Investment Growth Facility
ESIF Fund-of-Funds Czech Republic
ESIF Fund-of-Funds Greece
The Silesia EIF Fund of Funds
EstFund
FOSTER TPE-PME Occitanie
Greater Anatolia Guarantee Facility (GAGF)
G43 - Anatolian Venture Capital Fund Project
JEREMIE
LfA-EIF Facility
Luxembourg Future Fund (LFF)
Mezzanine 'Fund of Fund' for Germany (MDD)
Polish Growth Fund of Funds (PGFF)
Swedish Venture Initiative (SVI)
Turkish Growth and Innovation Fund (TGIF)
Scottish-European Growth Co-Investment Programme
Slovene Equity Growth Investment Programme (SEGIP)
The EIB Group Risk Enhancement Mandate (EREM)
Western Balkans Enterprise Development & Innovation Facility II (WB EDIF II)

SAS JEREMIE LR (France)

image

Medtech: Innovating beyond the conventional limits of imagination

It has been long discussed whether robots will replace human labour at some point. As controversial as this topic may seem, undoubtedly some areas exist where intelligent technology should be credited for helping us achieve previously unimaginable levels of precision and accuracy. Brain and spine surgery are prominent examples that should better not be left to luck.

The ROSA™ robotic devices, developed by the French company Medtech, were designed to increase the safety and reliability of various neurological interventions and procedures without compromising established surgical protocols, but acting as a reliable surgical assistant.

Medtech was set up in 2002 by Bertin Nahum, an expert of robot-assisted solutions for surgery who worked at leading companies for many years before setting up his own enterprise. Today, he employs more than 40 people.

Medtech has become very successful in a short time: first it launched an orthopedic surgical robot named BRIGIT™. Following the sale of BRIGIT™'s patent portfolio, Medtech created ROSA™ Brain and more recently, ROSA™ Spine. In essence, the mission of Medtech is to “broaden the use of medical technology for the benefit of both patient and practitioner as Medtech strives for improved overall health and well-being”, according to CEO Nahum.

ROSA™ Brain is like a GPS: ahead of the surgery, doctors can scan the patient’ brain and plan the intervention in advance using the collected preoperative data. In addition, the precise positioning and handling of instruments aids the surgeon in carrying out the operation. The device has a number of unique features – such as a robotic arm with six degrees of freedom, an advanced haptic capability as well as a laser measurement system that makes the earlier use of invasive markers or a frame superfluous. Thus, it enhances the comfort of both doctor and patient. ROSA™ Brain is most frequently used in curing diseases such as epilepsy, Parkinson’s or tumours. 

To support Medtech’s further growth, SAS JEREMIE LR – a financial intermediary under the JEREMIE Languedoc Roussillon initiative – invested in the company, supporting among others the development of ROSA™ Spine, the brand new robot that is currently being introduced throughout Europe and the United States. The region of Languedoc-Roussillon was the first in European to set up the JEREMIE initiative that is managed by EIF co-financed equally by the Languedoc-Roussillon region’s own resources as well as the European Regional Development Fund (ERDF).

Company: Medtech (France)

Type of business: Surgical technology, medical robotics

EU-supported EIF co-investment: JEREMIE Languedoc-Roussillon

For further information about EIF intermediaries in France, please refer to:
http://www.eif.org/what_we_do/where/fr


 
 

Copyright ©

 European Investment Fund 2017 – The European Investment Fund is not responsible for the content of external internet sites.